Pharma · on the rundown Tuesday, July 14, 2026
PBS review of MS treatments Ocrevus and Kesimpta reported
Covered by 11 outlets over 2 hours. First reported by maitlandmercury.com.au at 09:45 UTC on July 14, 2026.
- outlets11
- distinct reports11
- first to latest report2 h
- names in it2
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Jul 14 09:45 | Report by maitlandmercury.com.au |
|
| Jul 14 09:45 | Report by oberonreview.com.au |
|
| Jul 14 09:45 | Report by moreechampion.com.au |
|
| Jul 14 09:45 | Report by nvi.com.au |
|
| Jul 14 09:45 | Report by gloucesteradvocate.com.au |
|
| Jul 14 10:15 | Report by ulladullatimes.com.au |
|
| Jul 14 10:15 | Report by merimbulanewsweekly.com.au |
|
| Jul 14 10:15 | Report by tenterfieldstar.com.au |
|
| Jul 14 10:15 | Report by bunburymail.com.au |
|
| Jul 14 11:15 | Report by camdencourier.com.au |
|
| Jul 14 11:15 | Report by hardenexpress.com.au |
|
A report's title is shown once our automated legal check has read it and passed it; these reports are named by outlet, and the links lead to each report.
Who was named?
- Kesimpta (ofatumumab)
- Ocrevus (ocrelizumab)
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).